ORYZF (Oryzon Genomics) EV-to-OCF: (As of Aug. 09, 2026)

Oryzon Genomics  (OTCPK:ORYZF) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Oryzon Genomics's PE Ratio (TTM) for today is calculated as:

Oryzon Genomics's share price for today is $3.50.
Oryzon Genomics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.027.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Oryzon Genomics EV-to-OCF Related Terms

The historical data trend for Oryzon Genomics's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oryzon Genomics EV-to-OCF Chart

Oryzon Genomics Annual Data
	Trend	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24	Dec25
EV-to-OCF		Get a 7-Day Free Trial					-35.16	-73.11	-202.38	-16.91	-93.52

Oryzon Genomics Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
EV-to-OCF	Get a 7-Day Free Trial															0.00	0.00	-93.52	0.00	0.00

ORYZF vs VRTX, REGN, RVMD: EV-to-OCF Comparison

For the Biotechnology subindustry, Oryzon Genomics's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oryzon Genomics EV-to-OCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oryzon Genomics's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where Oryzon Genomics's EV-to-OCF falls into.

Oryzon Genomics EV-to-OCF Calculation

Oryzon Genomics's EV-to-OCF for today is calculated as:

Oryzon Genomics's current Enterprise Value is $264.63 Mil.
Oryzon Genomics's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oryzon Genomics Business Description